Endocrine Journal
Online ISSN : 1348-4540
Print ISSN : 0918-8959
ISSN-L : 0918-8959
Factors associated with the dawn phenomenon in adults with type 1 diabetes: a probabilistic continuous glucose monitoring analysis
Naoki Sakane , Yushi Hirota, Akane Yamamoto, Junnosuke Miura, Hiroko Takaike, Sari Hoshina, Masao Toyoda, Nobumichi Saito, Masaki Matsubara, Atsuhito Tone, Satoshi Kawashima, Hideaki Sawaki, Tomokazu Matsuda, Masayuki Domichi, Akiko Suganuma, Seiko Sakane, Takashi Murata, Hitoshi Ando
Author information
JOURNAL OPEN ACCESS Advance online publication
Supplementary material

Article ID: EJ26-0338

Details
Abstract

The dawn phenomenon (DP), an early-morning rise in glucose levels, remains a challenge in the management of type 1 diabetes mellitus (T1DM). This study aimed to identify factors associated with DP frequency in adults with T1DM. We analyzed data from 265 adults with T1DM enrolled in the FGM-Japan study. Continuous glucose monitoring (CGM) data obtained using the FreeStyle Libre system for approximately 90 days were analyzed. DP was defined as a glucose rise ≥20 mg/dL from the nocturnal nadir without preceding nocturnal hypoglycemia. DP probability was estimated using a probabilistic computation framework incorporating CGM sensor error. Multivariable linear regression and k-means clustering were used to identify factors and phenotypic patterns associated with DP. Sensitivity analyses were performed using alternative DP thresholds (≥10 mg/dL and ≥30 mg/dL). The mean DP frequency was 0.305 (95% CI, 0.288–0.323). Three clusters with increasing DP frequency were identified, characterized by male predominance, shorter diabetes duration, higher HbA1c levels, and greater post-breakfast glucose excursions. Continuous subcutaneous insulin infusion use was lowest in the highest-DP cluster and was associated with lower DP frequency. Male sex, higher HbA1c, and higher γ-glutamyl transferase levels were independently associated with greater DP. DP in adults with T1DM is associated with glycemic control and liver-related metabolic markers, particularly γ-glutamyl transferase. The trial was registered with the UMIN Clinical Trials Registry (UMIN-CTR; registration number UMIN000039376).

Fullsize Image
Content from these authors
© The Japan Endocrine Society

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Previous article Next article
feedback
Top